Deep Brain Stimulation Systems Market Size Worth USD 2,122.8 Million in 2027 | Rising Demand for Painless and Wireless Stimulation Systems and Rapid Technological Advancements are Key Factors Driving Industry Growth, says Emergen Research

Some major companies operating in the Deep Brain Stimulation Systems market include Abbott Laboratories, Medtronic, Aleva Neurotherapeutics, NeuroPace, Cyberonics, Boston Scientific Corporation, and Fisher Wallace among others.

Surrey, CANADA

Vancouver, British Columbia, April 06, 2021 (GLOBE NEWSWIRE) -- The global deep brain stimulation systems market size is expected to reach USD 2,122.8 Million in 2027 at a CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research. Increasing incidence of Parkinson’s disease, dystonia, epilepsy, and other involuntary movement disorders among the geriatric population are key factors expected to drive market revenue growth over the forecast period. According to some reports, over 60,000 individuals are diagnosed with Parkinson’s disease annually in the United States and around 10 million individuals are living with the disease across the globe. Increasing prevalence of such neurological conditions among the aging and elderly population and rapid increase in geriatric population across the globe are key factors boosting demand for deep brain stimulation systems globally. Furthermore, increasing incidence of depression, Obsessive Compulsive Disorder (OCD), and essential tremors are expected to further fuel demand for deep brain stimulation systems over the forecast period.

Claim Your FREE Sample Copy with Table of content@

Neurological symptoms such as tremors, movement control, and rigidity that are a characteristic of Parkinson’s disease and dystonia are generally treated through minimally invasive surgical procedures. The systems integrated in the deep brain ensures there is minimal to no damage to surrounding brain tissues. In addition, technologically advanced systems can be recharged wirelessly without needing further surgeries and this is expected to further boost demand for deep brain stimulation systems globally. However, some side effects associated with critical surgeries and drugs, high treatment costs, and high costs associated with deep brain stimulation systems can potentially hamper market growth to a certain extent over the forecast period.

Some Key Highlights From the Report:

  • Dual-channel deep brain stimulation systems product segment is expected to account for a significant revenue share in the global market over the forecast period, which can be attributable to increasing incorporation of advanced features such as wireless recharging and pain-free management in dual-channel systems to treat essential tremors associated with Parkinson’s disease.
  • Parkinson’s disease segment is expected to account largest revenue share in the global market over the forecast period owing to increasing occurrence of involuntary movements among a rapidly increasing geriatric population in countries across the globe.
  • Increasing pool of geriatric patients suffering from Parkinson’s disease, epilepsy, dystonia, and depression in countries such as India and China is expected to contribute to significantly to revenue growth of the market in Asia Pacific. Increasing awareness about deep brain stimulation systems and availability of proper treatments and technologically advanced facilities are factors expected to further fuel revenue growth of the market in the region.
  • North America accounted for largest revenue share in the global market in 2020 and is expected to register significant revenue growth over the forecast period. Steady growth can be attributed to increasing incidence of depression disorders, favorable reimbursement scenarios, rapid technological advancements in deep brain stimulation systems, and increasing product approvals from the U.S. FDA.
  • Some major companies operating in the market include Abbott Laboratories, Medtronic, Aleva Neurotherapeutics, NeuroPace, Cyberonics, Boston Scientific Corporation, and Fisher Wallace among others.
  • In January 2020, Abbott Laboratories received expanded indication from the U.S. FDA for directional deep brain stimulation systems for the treatment of Parkinson’s disease. The product is designed to also treat essential tremors along with Parkinson’s disease.  

Check Our Prices@

For the purpose of this report, Emergen Research has segmented the global deep brain stimulation systems market on the basis of product, application, end use, and region:

Product Outlook (Revenue, USD Million; 2017–2027)

  • Dual Channel
  • Single Channel

Application Outlook (Revenue, USD Million; 2017–2027)

  • Fluid Replacement
  • Parkinson’s disease
  • Pain Management
  • Obsessive-Compulsive Disorder (OCD)
  • Epilepsy
  • Essential Tremor
  • Depression
  • Dystonia
  • Other

End Use Outlook (Revenue, USD Million; 2017–2027)

  • Hospitals
  • Ambulatory Care Centre
  • Neurology Centers
  • Other

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

Regional Outlook (Revenue, USD Million; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • Rest of MEA

Take a Look at our Related Reports:

AI-Enabled Medical Imaging Solutions Market By Product (Software, Hardware), By Workflow (Image Acquisition, Image Analysis, Reporting, and Communication), By Therapeutic Application (General Imaging, Specialty Imaging), By Deployment Mode, By Modality, and By Region, Forecasts to 2027

Smart Factory Market By Component (Industrial Robotics, Sensors, Control Devices, Industrial Network, Machine Vision), By Solution (PLC, PLM, MES, ERP, SCADA), By Industries (Process Industries and Discrete Industries), Forecasts to 2027

Smart Manufacturing Market By Information Technology (Manufacturing Execution System, Industrial Communication), By Enabling Technology (Industrial Robotics, IIoT), By Industry (Aerospace & Defense, Automotive), Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@